However, silencing of BHMT not only decreased the production of SAM but also inhibited the m6A modification in HCC cells, while additional SAM supplementation counteracted the downregulation effect of BHMT (Figure 5K-M, Figure S4C and S4I). The gene discussed is BHMT; the disease is hepatocellular carcinoma.